• Maged D Fam, Daniel Hanley, Agnieszka Stadnik, Hussein A Zeineddine, Romuald Girard, Michael Jesselson, Ying Cao, Lynn Money, Nichol McBee, Amanda J Bistran-Hall, W Andrew Mould, Karen Lane, Paul J Camarata, Mario Zuccarello, and Issam A Awad.
• Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
• Neurosurgery. 2017 Nov 1; 81 (5): 860-866.

BackgroundMinimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hemorrhage Evacuation (MISTIE III).ObjectiveTo assess the accuracy of catheter placement and efficacy of hematoma evacuation in relation to surgical approach and surgeon experience.MethodsWe performed a trial midpoint interim assessment of 123 cases that underwent the surgical procedure. Accuracy of catheter placement was prospectively assessed by the trial Surgical Center based on prearticulated criteria. Hematoma evacuation efficacy was evaluated based on absolute volume reduction, percentage hematoma evacuation, and reaching the target end-of-treatment volume of <15 mL. One of 3 surgical trajectories was used: anterior (A), posterior (B), and lobar (C). Surgeons were classified based on experience with the MISTIE procedure as prequalified, qualified with probation, and fully qualified.ResultsThe average hematoma volume was 49.7 mL (range 20.0-124), and the mean evacuation rate was 71% (range 18.4%-99.8%). First placed catheters were 58% in good position, 28% suboptimal (but suitable to dose), and 14% poor (requiring repositioning). Posterior trajectory (B) was associated with significantly higher rates of poor placement (35%, P = .01). There was no significant difference in catheter placement accuracy among surgeons of varying experience. Hematoma evacuation efficacy was not significantly different among the 3 surgical approaches or different surgeons' experience.ConclusionOngoing surgical education and quality monitoring in MISTIE III have resulted in consistent rates of hematoma evacuation despite technical challenges with the surgical approaches and among surgeons of varying experience.Copyright © 2017 by the Congress of Neurological Surgeons

25 keywords...

hide…